Human Protein Reference Database (HPRD) () was developed to serve as a comprehensive collection of protein features, post-translational modifications (PTMs) and protein–protein interactions. Since the original report, this database has increased to >20 000 proteins entries and has become the largest database for literature-derived protein–protein interactions (>30 000) and PTMs (>8000) for human proteins. We have also introduced several new features in HPRD including: (i) protein isoforms, (ii) enhanced search options, (iii) linking of pathway annotations and (iv) integration of a novel browser, GenProt Viewer (), developed by us that allows integration of genomic and proteomic information. With the continued support and active participation by the biomedical community, we expect HPRD to become a unique source of curated information for the human proteome and spur biomedical discoveries based on integration of genomic, transcriptomic and proteomic data.
The
marine Streptomyces sp. CNQ-617 produces two
diastereomers, marineosins A and B. These are structurally related
to alkyl prodiginines, but with a more complex cyclization and an
unusual spiroaminal skeleton. We report the identification of the mar biosynthetic gene cluster and demonstrate production
of marineosins through heterologous expression in a S. venezuelae host named JND2. The mar cluster shares the same
gene organization and has high homology to the genes of the red cluster (which directs the biosynthesis of undecylprodiginine)
but contains an additional gene, named marA. Replacement
of marA in the JND2 strain leads to the accumulation
of premarineosin, which is identical to marineosin with the exception
that the middle pyrrole (Ring B) has not been reduced. The final step
of the marineosin pathway is thus a MarA catalyzed reduction of this
ring. Replacement of marG (a homologue of redG that directs undecylprodiginine cyclization to give
streptorubin B) in the JND2 strain leads to the loss of all spiroaminal
products and the accumulation of 23-hydroxyundecylprodiginine and
a shunt product, 23-ketoundecylprodiginine. MarG thus catalyzes the
penultimate step of the marineosin pathway catalyzing conversion of
23-hydroxyundecylprodiginine to premarineosin. The preceding steps
of the biosynthetic marineosin pathway likely mirror that in the red-directed biosynthetic process, with the exception of
the introduction of the hydroxyl functionality required for spiroaminal
formation. This work presents the first experimentally supported scheme
for biosynthesis of marineosin and provides a new biologically active
molecule, premarineosin.
As members of the proneural basic-helix-loop-helix (bHLH) family of transcription factors, Ascl1 and Neurog2 direct the differentiation of specific populations of neurons at various times and locations within the developing nervous system. In order to characterize the mechanisms employed by these two bHLH factors, we generated stable, doxycycline-inducible lines of P19 embryonic carcinoma cells that express comparable levels of Ascl1 and Neurog2. Upon induction, both Ascl1 and Neurog2 directed morphological and immunocytochemical changes consistent with initiation of neuronal differentiation. Comparison of Ascl1- and Neurog2-regulated genes by microarray analyses showed both shared and distinct transcriptional changes for each bHLH protein. In both Ascl1- and Neurog2-differentiating cells, repression of Oct4 mRNA levels was accompanied by increased Oct4 promoter methylation. However, DNA demethylation was not detected for genes induced by either bHLH protein. Neurog2-induced genes included glutamatergic marker genes while Ascl1-induced genes included GABAergic marker genes. The Neurog2-specific induction of a gene encoding a protein phosphatase inhibitor, Ppp1r14a, was dependent on distinct, canonical E-box sequences within the Ppp1r14a promoter and the nucleotide sequences within these E-boxes were partially responsible for Neurog2-specific regulation. Our results illustrate multiple novel mechanisms by which Ascl1 and Neurog2 regulate gene repression during neuronal differentiation in P19 cells.
Cognitive dysfunction in aging is a major biomedical challenge. Whether treatment with klotho, a longevity factor, could enhance cognition in human-relevant models such as in nonhuman primates is unknown and represents a major knowledge gap in the path to therapeutics. We validated the rhesus form of the klotho protein in mice showing it increased synaptic plasticity and cognition. We then found that a single administration of low-dose, but not high-dose, klotho enhanced memory in aged nonhuman primates. Systemic low-dose klotho treatment may prove therapeutic in aging humans.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.